Immatics (IMTX) Free Cash Flow (2019 - 2025)
Immatics (IMTX) reported Free Cash Flow of -$67.2 million for Q4 2025, down 10.64% on a YoY basis from -$75.2 million in Q4 2024, and down 31.72% sequentially from -$51.0 million in Q3 2025.
Immatics (IMTX) Free Cash Flow (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Free Cash Flow data on file, last reported at -$67.2 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 10.64% year-over-year to -$67.2 million; the trailing twelve-month figure through Dec 2025 stood at -$193.5 million (down 26.41% YoY), and the FY2025 full-year result was -$192.1 million, down 25.23% from the prior year.
- Free Cash Flow eased to -$67.2 million in Q4 2025, from -$51.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $121.8 million in Q1 2022 to a low of -$67.2 million in Q4 2025.
- A 5-year average of -$18.2 million and a median of -$26.5 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow surged 727.62% in 2022 and tumbled 841.82% in 2024, its largest moves.
- Tracing IMTX's Free Cash Flow over 5 years: stood at -$26.8 million in 2021, then slumped by 54.43% to -$41.4 million in 2022, then soared by 169.58% to $28.8 million in 2023, then plunged by 310.72% to -$60.7 million in 2024, then fell by 10.64% to -$67.2 million in 2025.
- Business Quant data shows IMTX's Free Cash Flow at -$67.2 million in Q4 2025, -$51.0 million in Q3 2025, and -$42.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -67.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.16 Mn |
| Dec 31, 2025 | -67.16 Mn |
| Sep 30, 2025 | -50.99 Mn |
| Sep 30, 2025 | -50.99 Mn |
| Jun 30, 2025 | -42.59 Mn |
| Jun 30, 2025 | -42.59 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Dec 31, 2024 | -60.70 Mn |
| Dec 31, 2024 | -60.70 Mn |
| Sep 30, 2024 | -33.97 Mn |
| Sep 30, 2024 | -33.97 Mn |
| Jun 30, 2024 | -32.95 Mn |
| Jun 30, 2024 | -32.95 Mn |
| Mar 31, 2024 | -25.45 Mn |
| Mar 31, 2024 | -25.45 Mn |
| Dec 31, 2023 | 28.81 Mn |
| Dec 31, 2023 | 28.81 Mn |
| Sep 30, 2023 | -26.15 Mn |
| Sep 30, 2023 | -26.15 Mn |